{
    "clinical_study": {
        "@rank": "83911", 
        "brief_summary": {
            "textblock": "This study was a survey to determine the frequency of Complementary and Alternative Medicine\n      (CAM) use in patients recently diagnosed with breast or prostate cancer who were starting\n      radiation therapy.  The survey was repeated at three time points to assess changes in CAM\n      use over time."
        }, 
        "brief_title": "Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer Patients", 
        "condition": [
            "Prostate Cancer Patients", 
            "Breast Cancer Patients"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Breast Neoplasms", 
                "Prostatic Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion/Exclusions\n\n          -  Men that have histologically proven carcinoma of the prostate and have chosen some\n             form of radiation therapy as their primary therapy for prostate cancer.\n\n          -  Women who are undergoing external beam radiation therapy to the breast as primary or\n             adjuvant therapy are eligible.\n\n          -  All participants must be able to read and write.\n\n          -  Subjects with dementia and mental retardation that complicates completing the\n             questionnaires will not be enrolled.\n\n          -  Subjects with known metastatic disease will be excluded.\n\n          -  There are no age restrictions for this study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "21 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Men with clinically localized prostate cancer that have chosen external beam irradiation\n        or brachytherapy or a combination for their treatment and women with localized breast\n        cancer who are scheduled to begin external beam radiation therapy as a component of their\n        primary or adjuvant therapy."
            }
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01823549", 
            "org_study_id": "OSU-0240"
        }, 
        "intervention": {
            "arm_group_label": [
                "Breast, Prostate Cancer patients Radiotherapy", 
                "Arm II (carbon C 13 phytofluene)", 
                "Arm III (carbon C 13 lycopene)"
            ], 
            "description": "Ancillary studies", 
            "intervention_name": "questionnaire administration", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "CAM", 
            "Alternative Medicine"
        ], 
        "lastchanged_date": "April 2, 2013", 
        "link": {
            "description": "Jamesline", 
            "url": "http://cancer.osu.edu"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Columbus", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "43210"
                }, 
                "name": "Ohio State University Comprehensive Cancer Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Use of Nutritional Supplements and CAM (Complementary and Alternative Medicine) by Prostate and Breast Cancer Patients Undergoing Radiotherapy", 
        "overall_official": {
            "affiliation": "Ohio State University Comprehensive Cancer Center", 
            "last_name": "Steven Clinton, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United States: Federal Government"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Quantitate the various types of CAM therapy utilized by men with prostate cancer and women with breast cancer who are currently undergoing radiation therapy at The James Cancer Hospital and Solove Research Institute. Nutrient supplements and alternative medication use is the primary focus of the assessment.", 
                "measure": "Quantitate the various types of CAM therapy utilized by men with prostate cancer and women with breast cancer who are currently undergoing radiation.", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 year"
            }, 
            {
                "measure": "Determine if patients change their patterns of CAM use prior to, during, or after radiation treatment.", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 year"
            }, 
            {
                "measure": "Assess quality of life using validated instruments during radiation therapy and determine if there is a correlation between CAM use and quality of life.", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 year"
            }, 
            {
                "measure": "Assess radiation therapy toxicity using standardized criteria from the Oncology Nursing Society and determine if there is a correlation between CAM use and quality of life.", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 1 year"
            }, 
            {
                "measure": "To determine predictive factors for CAM and nutritional supplement use, such as age, race, income, education, marital status, or tobacco/alcohol use. Study Plan:", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 year"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01823549"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ohio State University Comprehensive Cancer Center", 
            "investigator_full_name": "Steven Clinton", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Ohio State University Comprehensive Cancer Center", 
        "sponsors": {
            "collaborator": {
                "agency": "National Center for Complementary and Alternative Medicine (NCCAM)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Ohio State University Comprehensive Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2011", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2013"
    }
}